Follow The Filings

PEN Penumbra Inc.

Health Care, filed as PENUMBRA INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 exit

In 2026 Q2 George Soros sold out of Penumbra.

Who owns PEN

Sorted by value, long equity only, as of 2026 Q2.

History
George Soros, Soros Fund Management exited 2026 Q2 Last 2026 Q1 0.73% Exit −0.73% 203,434 $67M History

0 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by PEN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PEN insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $11.1M sold by 5 insiders under 10b5-1 plans
  1. Harpreet Grewal Director
    Planned sale
    $33K 100 shares at $328.22 1.1% of stake
    Traded Apr 2 Filed Apr 6
    ↗
  2. Maggie Yuen CFO
    Planned sale
    $832K 2,432 shares at $342.30 12% of stake
    Traded Mar 2 Filed Mar 4
    ↗
  3. Harpreet Grewal Director
    Planned sale
    $58K 186 shares at $312.64 2.2% of stake
    Traded Jan 6 Filed Jan 8
    ↗
  4. Thomas Wilder Director
    Planned sale
    $58K 186 shares at $310.72 100% of stake
    Traded Jan 2 Filed Jan 6
    ↗
  5. Arani Bose Director
    Planned sale
    $4.6M 15,000 shares at $308.82 5.5% of stake
    Traded Dec 11, 2025 Filed Dec 15, 2025
    ↗
  6. Johanna Roberts EVP, Gen. Counsel & Secretary
    Planned sale
    $90K 300 shares at $300.13 0.5% of stake
    Traded Dec 5, 2025 Filed Dec 9, 2025
    ↗
  7. Johanna Roberts EVP, Gen. Counsel & Secretary
    Planned sale
    $177K 600 shares at $294.94 0.9% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
    ↗
  8. Harpreet Grewal Director
    Planned sale
    $29K 100 shares at $292.98 1.2% of stake
    Traded Dec 2, 2025 Filed Dec 3, 2025
    ↗
  9. Johanna Roberts EVP, Gen. Counsel & Secretary
    Planned sale
    $540K 1,800 shares at $300.06 2.7% of stake
    Traded Nov 25, 2025 Filed Nov 26, 2025
    ↗
  10. Arani Bose Director
    Planned sale
    $2.3M 7,500 shares at $300.19 2.7% of stake
    Traded Nov 25, 2025 Filed Nov 26, 2025
    ↗
  11. Arani Bose Director
    Planned sale
    $2.2M 7,500 shares at $290.56 2.6% of stake
    Traded Nov 21, 2025 Filed Nov 25, 2025
    ↗
  12. Johanna Roberts EVP, Gen. Counsel & Secretary
    Planned sale
    $160K 600 shares at $266.98 0.9% of stake
    Traded Nov 10, 2025 Filed Nov 12, 2025
    ↗
  13. Harpreet Grewal Director
    Planned sale
    $42K 186 shares at $227.58 2.1% of stake
    Traded Nov 4, 2025 Filed Nov 6, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 21 share withholdings for taxes, 18 stock grants, and 2 gifts.

Congress

1 member of Congress traded PEN in the last three years: 0 buys and 1 sale.

All Congress trades
  1. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Jul 10, 2025 filed Aug 13, 2025

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,2.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Gross profit $682.64M $755M $942.44M
Net income $90.95M $14.01M $177.69M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $0.915B $0.951B $1.22B
Total non-current assets * $640.9M $582.06M $609.84M
Total assets $1.56B $1.53B $1.83B
Total current liabilities $151.14M $158.34M $183.13M
Total non-current liabilities * $226.22M $223.9M $215.78M
Total equity — $1.15B $1.43B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $97.33M $168.48M $238.66M
Cash from investing -$16.08M $77.62M -$404.59M
Cash from financing $16.2M -$87.01M $26.53M
Net change in cash $97.63M $156.92M -$137.51M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.